![]() |
市場調查報告書
商品編碼
2058703
低升糖指數食品市場預測至2034年-按產品類型、原料類型、分銷管道、應用和最終用戶分類的全球分析Low-Glycemic Index Foods Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Distribution Channel, Application, and End User |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球低升糖指數食品市場規模將達到 91 億美元,並在預測期內以 14.1% 的複合年成長率成長,到 2034 年將達到 258 億美元。
低升糖指數(GI)食物是指能緩慢提升血糖血糖值。這類食物對糖尿病患者、體重管理者以及希望維持整體代謝健康的人有好處。低升糖指數食物包括全穀穀物、豆類、某些水果和特殊配方食品。糖尿病盛行率的上升和人們健康飲食習慣的普及推動了市場對低升糖指數食物的需求。生產商正在開發各種食品類別的低升糖指數替代品,以支持更健康的飲食選擇。
全球糖尿病盛行率不斷上升
隨著健康意識的增強,人們對血糖值控制的關注度日益提高,這推動了低升糖指數(GI)食品的需求成長。消費者積極尋求更健康的飲食選擇,醫療保健專業人員也建議控制碳水化合物的攝取。機能性食品正逐漸成為日常營養計畫的重要一環。隨著人們健康意識的提高,市場需求持續穩定成長。
難以取得地理標示產品
許多食品包裝上並未清楚標示其升糖指數(GI)值,限制了消費者做出明智選擇的能力。標籤標準化程度不足降低了產品透明度,消費者可能難以找到合適的選項。在某些地區,獲得GI認證的產品在商店上的供應仍然有限。製造商在獲得相關認證方面也面臨挑戰。這些因素可能會阻礙市場成長。
糖尿病患者食品的產品創新
各公司正在研發日常食品的低升糖指數版本。這些產品使消費者無需大幅改變飲食習慣即可控制血糖值。研發工作正推動更健康配方的開發。品牌正著力提升產品的品味與便利性以吸引消費者。產品類型的拓展正在擴大市場覆蓋率。預計這一趨勢將創造強勁的成長機會。
消費者對升糖指數的困惑
消費者對升糖指數(GI)的運作機制了解不足,導致在選擇合適的食物時感到困惑。對GI的誤解可能導致錯誤的選擇。缺乏清晰的教育阻礙了產品的普及。行銷宣傳也可能加劇這種困惑。消費者可能依賴不完整或不準確的資訊。這些問題會對市場成長產生負面影響。
疫情提高了人們對糖尿病等慢性疾病管理的認知。消費者更意識到飲食在維持健康的重要性。在此期間,低升糖指數食品和機能性食品的需求增加。線上生鮮平台的使用量也隨之成長。品牌透過強調健康益處來吸引消費者。初期,供應鏈中斷影響了產品的供應。總體而言,疫情期間及之後,市場保持了穩定成長。
在預測期內,低升糖指數烘焙產品細分市場預計將佔據最大佔有率。
低升糖指數烘焙產品,包括有助於控制血糖值的麵包和餅乾,預計將在預測期內佔據最大的市場佔有率。這些產品易於融入日常膳食。消費者對更健康的烘焙產品的需求日益成長。他們希望這些產品既美味又健康。零售通路的廣泛覆蓋範圍也促進了其受歡迎程度。原料的持續創新正在提升產品品質。這些因素預計將維持該細分市場的領先地位。
在預測期內,專注於體重管理的消費群體預計將呈現最高的複合年成長率。
在預測期內,體重管理消費群體預計將呈現最高的成長率,這主要得益於注重健康的消費者對卡路里控制和均衡營養日益成長的興趣。低升糖指數(低GI)食品有助於維持穩定的能量水平。消費者選擇這類產品是為了實現他們的減重目標。人們對肥胖問題的日益關注正在影響他們的飲食選擇。健身潮流也在推動更健康的飲食習慣。每個品牌都針對這個細分市場推出了專門的產品。預計這些因素將推動該細分市場的快速成長。
在預測期內,北美預計將佔據最大的市場佔有率。這主要歸功於美國和加拿大糖尿病的高發生率,以及消費者在先進醫療指導下對健康飲食習慣的強烈認知。消費者正積極將低升糖指數(低GI)食品納入日常飲食管理。知名食品品牌的存在也推動了市場成長。先進的零售和線上通路提高了產品的可近性。產品創新也激發了消費者的興趣。較高的購買力也進一步促進了低GI食品的普及。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於印度、中國和日本等國家糖尿病盛行率的上升,以及人們對飲食管理和預防保健意識的增強。人口成長推動了對特色食品需求的成長。都市化正在促使人們的飲食習慣轉向更健康的選擇。零售和電子商務平台的擴張提高了產品的供應量。區域和國際品牌正在加大在該地區的投入。日益增強的健康意識也為該地區的進一步成長提供了支持。
According to Stratistics MRC, the Global Low-Glycemic Index Foods Market is accounted for $9.1 billion in 2026 and is expected to reach $25.8 billion by 2034 growing at a CAGR of 14.1% during the forecast period. Low-Glycemic Index Foods are foods that release glucose slowly into the bloodstream, helping maintain stable blood sugar levels. These products are beneficial for individuals managing diabetes, weight, and overall metabolic health. They include whole grains, legumes, certain fruits, and specially formulated food products. Increasing prevalence of diabetes and health-conscious eating habits are driving demand. Manufacturers are developing low-GI alternatives across various food categories to support healthier dietary choices.
Rising prevalence of diabetes globally
Growing health concerns are raising awareness about blood sugar control. This is driving demand for low-glycemic index foods. Consumers are actively seeking healthier dietary options. Medical advice is encouraging controlled carbohydrate intake. Functional foods are becoming part of daily nutrition plans. As awareness rises, market demand continues to expand steadily.
Limited availability of GI-labeled products
Few food products do not clearly display their glycemic index values on packaging. This limits consumer ability to make informed choices. Lack of standardized labeling reduces product transparency. Consumers may struggle to identify suitable options. Retail availability of GI-certified products is still limited in some regions. Manufacturers face challenges in obtaining proper certifications. These factors can restrict market growth.
Product innovation in diabetic-friendly foods
Companies are developing low-GI versions of everyday food items. These products allow consumers to manage blood sugar without changing diets drastically. Research is supporting the development of healthier formulations. Brands are focusing on taste and convenience to attract consumers. Expansion of product categories is improving market reach. This trend is expected to create strong growth opportunities.
Consumer confusion on glycemic indexing
Consumers do not fully understand how glycemic index works. This creates confusion when selecting suitable food products. Misinterpretation of GI values can lead to incorrect choices. Lack of clear education affects product adoption. Marketing claims may also add to confusion. Consumers may rely on incomplete or inaccurate information. These issues can negatively impact market growth.
The pandemic increased focus on managing chronic health conditions such as diabetes. Consumers became more aware of the importance of diet in maintaining health. Demand for low-GI and functional foods increased during this period. Online grocery platforms saw higher adoption. Brands promoted health benefits to attract consumers. Supply chain disruptions affected product availability in early stages. Overall, the market experienced steady growth during and after the pandemic.
The low-GI bakery products segment is expected to be the largest during the forecast period
The low-GI bakery products segment is expected to account for the largest market share during the forecast period as bread and biscuits while managing blood sugar levels. These products allow easy integration into daily diets. Demand for healthier bakery alternatives is increasing. Consumers seek both taste and health benefits in such products. Wide availability across retail channels supports adoption. Continuous innovation in ingredients improves product quality. These factors are expected to sustain the segment's dominant position.
The weight management consumers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the weight management consumers segment is predicted to witness the highest growth rate due to increasing focus on calorie control and balanced nutrition among health-conscious individuals. Low-GI foods help in maintaining steady energy levels. Consumers are choosing these products to support weight loss goals. Rising obesity concerns are influencing dietary choices. Fitness trends are encouraging healthier eating habits. Brands are targeting this segment with specialized offerings. These factors are expected to drive rapid growth in this segment.
During the forecast period, the North America region is expected to hold the largest market share owing to high prevalence of diabetes and strong awareness of healthy eating habits in the United States and Canada supported by advanced healthcare guidance. Consumers actively adopt low-GI foods as part of diet management. Presence of established food brands supports market growth. Advanced retail and online channels improve accessibility. Product innovation is also driving consumer interest. High spending capacity further boosts adoption.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by increasing diabetes cases in countries such as India, China, and Japan along with rising awareness of dietary management and preventive healthcare. Growing population is supporting higher demand for specialized foods. Urbanization is influencing dietary habits toward healthier options. Expansion of retail and e-commerce platforms improves product availability. Local and global brands are increasing their presence in the region. Rising health consciousness is further supporting growth.
Key players in the market
Some of the key players in Low-Glycemic Index Foods Market include Nestle S.A., Kellogg Company, General Mills, Inc., PepsiCo, Inc., Mondelez International, Danone S.A., Abbott Laboratories, Unilever plc, The Coca-Cola Company, Dabur India Ltd., Himalaya Wellness Company, Atkins Nutritionals, SlimFast, Nature's Path Foods and Quaker Oats Company.
In February 2026, PepsiCo finalized a strategic agreement with Elliott Investment Management to restructure its U.S. product lineup, resulting in a 20% reduction of low-performing SKUs. This collaboration involves reallocating savings into automation and price cuts for core "better-for-you" brands, specifically targeting cost-conscious consumers who prioritize metabolic health through affordable low-GI options.
In November 2024, Danone was ranked first in the Global Access to Nutrition Index (ATNi) for its industry-leading efforts in portfolio health and transparency. This strategic recognition highlights Danone's collaboration with global nutrition stakeholders to utilize nutrient profiling models, ensuring that a significant majority of its dairy and plant-based sales are derived from products with a low impact on blood glucose.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.